Simon C. Pedder
Simon C. Pedder is a businessperson who founded Chelsea Therapeutics International Ltd. and who has been at the head of 6 different companies. Currently, he is Executive Chairman & President at Cerecor, Inc. He is also on the board of Eboo Pharmaceuticals, Inc., Ballantyne Therapeutics, Inc. and Atlantic Research Group, Inc. and Chief Business & Strategy Officer-Proprietary at Athenex, Inc.
In his past career he occupied the position of President, Chief Executive Officer & Director at Cellectar BioSciences, Inc. and Chief Executive Officer & Director at Novelos Therapeutics, Inc. (a subsidiary of Cellectar BioSciences, Inc.), President, Chief Executive Officer & Director at Chelsea Therapeutics International Ltd., President & Chief Executive Officer of Chelsea Therapeutics, Inc., President & Chief Executive Officer of Ivory Capital Corp., Vice President-Pharmaceutical Business & Oncology at Hoffmann-La Roche, Inc., Vice President-Drug Development at Shearwater Corp. and Member of the University of Saskatchewan College of Medicine.
He received an undergraduate degree from The University of Waterloo, a graduate degree from Concordia University and a doctorate from the University of Saskatchewan College of Medicine.
|04/09/2020||20,901||Derivative/Non-derivative trans. at $2.57 per share.||53,716|
|08/27/2019||6,734||Acquisition at $2.98 per share.||20,067|
|05/24/2019||250,000||Award at $0 per share.||0|
|05/14/2019||6,000||Acquisition at $5.06 per share.||30,360|